Cost-Effectiveness of Nivolumab (NIVO) Combined with Ipilimumab (IPI) Compared with Nivo and Ipi Monotherapies in The First-Line Treatment of Advanced Melanoma in The United States- Analysis Using 28-Month Overall Survival (OS) Data from Ch ...

Oct 1, 2017, 00:00 AM
Section Title : Disease-Specific Studies
Section Order : 199
First Page : A436
HEOR Topics :
Tags :
Regions :